Practical management of liver transplant recipients for hepatitis C
| Autor: | S, Saab, R W, Busuttil |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Liver Cirrhosis
Reoperation Interferon-alpha Hepacivirus Hepatitis C Chronic Interferon alpha-2 Antiviral Agents Combined Modality Therapy Recombinant Proteins Liver Transplantation Polyethylene Glycols Treatment Outcome Recurrence Ribavirin Disease Progression Humans Immunosuppressive Agents Randomized Controlled Trials as Topic |
| Zdroj: | Minerva chirurgica. 58(4) |
| ISSN: | 0026-4733 |
| Popis: | Hepatitis C is one of the leading indications for liver transplantation. Recipients can expect at least a short-term survival equivalent to other indications for liver transplantation. However, the rates of cirrhosis and decompensation development is substantially faster than those rates seen in non-transplant setting. Advances in antiviral therapy are now associated with a sustained virological response of 20% with combination antiviral with interferon and ribavirin. Higher response rates are expected with utilizing pegylated interferon. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|